TK1 and colorectal carcinoma: A meta-analysis suggested significantly worse survival among CRC patients with elevated TK1 levels (>0.9 pmol/L) in comparison to those with low TK1 values (<=0.9 pmol/L) and cox regression analysis showcased TK1, clinicopathological stage and lymph node status to be independent factors for prognosis.